Last update 01 Nov 2024

VEGFR2 x HDAC6 x AXL

Basic Info

Related Targets
VEGFR2HDAC6AXL

Related

1
Drugs associated with VEGFR2 x HDAC6 x AXL
CX-1026
Target
AXL x HDAC6 x VEGFR2
Mechanism
AXL inhibitors [+2]
Active Org.
Beijing Konruns Biotechnology Co., Ltd.Beijing Konruns Biotechnology Co., Ltd.
Originator Org.
Beijing Konruns Pharmaceutical Co., Ltd.Beijing Konruns Pharmaceutical Co., Ltd.
Active Indication
Colonic Cancer [+3]
Inactive Indication
Acute Myeloid Leukemia [+2]
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with VEGFR2 x HDAC6 x AXL
Login to view more data
100 Translational Medicine associated with VEGFR2 x HDAC6 x AXL
Login to view more data
0 Patents (Medical) associated with VEGFR2 x HDAC6 x AXL
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free